Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Primary Central Nervous System Neoplasm — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Nervous System Neoplasm
Central Nervous System Neoplasm
Primary Central Nervous System Neoplasm

Subtype

Primary Central Nervous System Neoplasm

CI-CAN-00001432Explore in graph →

Non-malignant957 active trials5 approved drugs175 evidence items

NCIt: C102871

Overview
Statistics
Survival
Genomics32
Variants & evidence175
Drugs37
Trials3293
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

3,293 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

StatusAll Active (any)Completed 1,236 Recruiting 641 Unknown 391 Terminated 351 Active Not Recruiting 289 Not Yet Recruiting 179 Withdrawn 131 Suspended 30 No Longer Available 17 Enrolling By Invitation 16 Available 9 Approved For Marketing 3

PhaseAll Early Phase 1 155 N/A 487 Phase 1 1,064 Phase 2 1,240 Phase 3 173 Phase 4 22

No study matches these filters